These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20721792)

  • 1. Comment on: Cheng, Chow, Burt, and Cosmatos (2008). Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables. Journal of Biopharmaceutical Statistics 18(3):494-501.
    Sebastien B
    J Biopharm Stat; 2010 Sep; 20(5):1071-3; author reply 1074. PubMed ID: 20721792
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
    Cheng B; Chow SC; Burt D; Cosmatos D
    J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The joint modeling of drug and positive control effects to estimate sample size and power in crossover "thorough" QT/QTc studies.
    Hosmane B; Locke C; Chiu YL
    J Biopharm Stat; 2013; 23(4):871-80. PubMed ID: 23786591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
    Tsong Y; Zhong J
    J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical issues including design and sample size calculation in thorough QT/QTc studies.
    Zhang J; Machado SG
    J Biopharm Stat; 2008; 18(3):451-67. PubMed ID: 18470755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate dependent modification of the QTc cut-off values can improve accurate evaluation of QT prolongation.
    Sadanaga T; Sadanaga F; Yao H; Fujishima M
    Am J Cardiol; 2004 Mar; 93(6):772-5. PubMed ID: 15019891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculations in thorough QT studies.
    Zhang L; Dmitrienko A; Luta G
    J Biopharm Stat; 2008; 18(3):468-82. PubMed ID: 18470756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On power and sample size calculation for QT studies with recording replicates at given time point.
    Chow SC; Cheng B; Cosmatos D
    J Biopharm Stat; 2008; 18(3):483-93. PubMed ID: 18470757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation.
    Schall R; Ring A
    Pharm Stat; 2011; 10(3):265-76. PubMed ID: 21574242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical characterization of QT prolongation.
    Schall R; Ring A
    J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size and power estimation in "thorough" QT/QTc studies with parallel group design.
    Hosmane B; Locke C; Chiu YL
    J Biopharm Stat; 2010 May; 20(3):578-86. PubMed ID: 20358437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical issues of QT prolongation assessment based on linear concentration modeling.
    Tsong Y; Shen M; Zhong J; Zhang J
    J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias and variance evaluation of QT interval correction methods.
    Wang Y; Pan G; Balch A
    J Biopharm Stat; 2008; 18(3):427-50. PubMed ID: 18470754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical analysis methods for QT/QTc prolongation.
    Ma H; Smith B; Dmitrienko A
    J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT analysis: a complex answer to a 'simple' problem.
    Li L; Desai M; Desta Z; Flockhart D
    Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points.
    Meng Z; Kringle R; Chen X; Zhao PL
    J Biopharm Stat; 2010 May; 20(3):563-77. PubMed ID: 20358436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability.
    Malik M; Zhang J; Johannesen L; Hnatkova K; Garnett C
    Heart Rhythm; 2011 Nov; 8(11):1777-85. PubMed ID: 21699874
    [No Abstract]   [Full Text] [Related]  

  • 20. A Bayesian measurement error approach to QT interval correction and prolongation.
    Chen J; Zhao X
    J Biopharm Stat; 2010 May; 20(3):523-42. PubMed ID: 20358434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.